Sandra Filla - Concepedia

Author

Sandra Filla

Eli Lilly (United States)

Also Known As

Filla, Sandra A., S. A. FILLA, S.A. Filla, Sandra A Filla, Sandra A. Filla, Sandra Filla

Publications

625

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Massachusetts Institute of Technology Eli Lilly (Spain)

About

Sandra Filla is an author at Eli Lilly (United States) specializing in natural sciences, organic chemistry, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	130
2	Natural Sciences	5	5	198
3	Engineering	4	4	147
4	Health Sciences	1	1	38
5	Social Sciences	1	1	13

Sandra Filla

Publications

531

Citations

H-Index

Page 1

	Year	Citations
Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo Brianne Weiss, Andrew Alt, Ann Marie L. Ogden, Journal of Pharmacology and Experimental Therapeutics	2006	74
Benzopyranoisoxazolidines as Chiral Auxiliaries for Asymmetric Synthesis Atsushi Abiko, Osamu Moriya, Sandra Filla, Angewandte Chemie International Edition in English Asymmetric CatalysisEngineeringChiral AuxiliariesNatural SciencesDiversity-oriented Synthesis	1995	69
The Synthesis of Naturally Occurring ()‐Calyculin A Norihiko Tánimoto, Samuel W. Gerritz, Akiyoshi Sawabe, Angewandte Chemie International Edition in English	1994	68
Ethyl (3<i>S</i>,4a<i>R</i>,6<i>S</i>,8a<i>R</i>)-6-(4-Ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic Ester: A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Models of Acute Migraine Sandra Filla, Mark A. Winter, Kirk W. Johnson, Journal of Medicinal Chemistry Diethyl EsterPharmacotherapyExperimental Pharmacology4-Ethoxycar- Bonylimidazol-1-ylmethylMolecular Pharmacology	2002	51
Discovery of (+)-<i>N</i>-(3-Aminopropyl)-<i>N</i>-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-<i>d</i>]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent Maria‐Elena Theoclitou, Brian Aquila, M. Block, Journal of Medicinal Chemistry	2011	43
Novel Potent 5-HT<sub>1F</sub> Receptor Agonists: Structure−Activity Studies of a Series of Substituted <i>N</i>-[3-(1-Methyl-4-piperidinyl)-1<i>H</i>-pyrrolo[3,2-<i>b</i>]pyridin-5-yl]amides Sandra Filla, Brian M. Mathes, Kirk W. Johnson, Journal of Medicinal Chemistry	2003	39
Two Prodrugs of Potent and Selective GluR5 Kainate Receptor Antagonists Actives in Three Animal Models of Pain Esteban Domı́nguez, Smriti Iyengar, Harlan E. Shannon, Journal of Medicinal Chemistry Pain TherapyPain MedicineNeuropathic PainMolecular PainPharmacotherapy	2005	38
A general method for the preparation of 2,3,5-trisubstituted-furo[3,2-b]pyridines Brian M. Mathes, Sandra Filla Tetrahedron Letters Organic ChemistryHeterocycle ChemistryChemistryGeneral MethodSynthetic Chemistry	2003	30
Synthesis of C1-C8 and C9-C24 fragments of (−)-discodermolide: use of asymmetric alkylation and stereoselective aldol reactions Sandra Filla, Jinhua J. Song, Lih-Ren Chen, Tetrahedron Letters EngineeringNatural SciencesDiversity-oriented SynthesisAsymmetric AlkylationC9-c24 Fragments	1999	29
Use of 2-trimethylsilylethyl as a protecting group in phosphate monoester synthesis Akiyoshi Sawabe, Sandra Filla, Satoru Masamune Tetrahedron Letters EngineeringPhosphate Monoester SynthesisBiocatalysisNatural SciencesOrganic Chemistry	1992	27

Page 1